Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis

Author： Boersma Cornelis   Broere Adriaan   Postma Maarten J.  

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.6, 2010-09, pp. : 853-856

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combining a Budgetary-Impact Analysis and a Cost-Effectiveness Analysis Using Decision-Analytic Modelling Techniques

By Nuijten M.J.C.  

PharmacoEconomics, Vol. 20, Iss. 12, 2002-01 ,pp. : 855-867

Adis International

Access to resources Recommend Favorite

Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis

By Hoyle Martin  

PharmacoEconomics, Vol. 29, Iss. 1, 2011-01 ,pp. : 1-15

Adis International

Access to resources Recommend Favorite

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine   Shabaruddin Fatiha H  

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

An Outline For a Cost-Effectiveness Analysis of a Drug For Patients With Alzheimer's Disease

By Busschbach J.J.V.  

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 21-34

Adis International

Access to resources Recommend Favorite

Estimating `Costs' for Cost-Effectiveness Analysis

By Miners Alec  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 745-751

Adis International

Access to resources Recommend Favorite